A case of eosinophilic polyangiitis with granulomatosis that evolved to cardiac arrest due to advanced atrioventricular block

1 Churg J, Strauss L. Allergic granulomatosis, allergic angiitis, and periarteritis nodosa. Am J Pathol.

1951;27(2):277–301.

2 Guillevin L, Pagnoux C, Seror R, et al. The five-factor score revisited: assessment of prognosis of systemic

necrotizing vasculitides based on the French Vasculitis Study Group (FVSG) Cohort. Medicine (Baltimore).

2011;90(1):19–27. doi:10.1097/MD.0b013e318205a4c6.

Nagoya J. Med. Sci. 85. 171–178, 2023

176

doi:10.18999/nagjms.85.1.171

EGPA with advanced AVB

3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 Guillevin L, Cohen P, Gayraud M, Lhote F, Jarrousse B, Casassus P. Churg-Strauss syndrome. Clinical study

and long-term follow-up of 96 patients. Medicine (Baltimore). 1999;78(1):26–37. doi:10.1097/00005792199901000-00003.

Comarmond C, Pagnoux C, Khellaf M, et al. Eosinophilic granulomatosis with polyangiitis (Churg-Strauss):

clinical characteristics and long-term followup of the 383 patients enrolled in the French Vasculitis Study

Group cohort. Arthritis Rheum. 2013;65(1):270–281. doi:10.1002/art.37721.

Moosig F, Bremer JP, Hellmich B, et al. A vasculitis centre based management strategy leads to improved

outcome in eosinophilic granulomatosis and polyangiitis (Churg-Strauss, EGPA): monocentric experiences

in 150 patients. Ann. Rheum. Dis. 2013;72(6):1011–1017. doi:10.1136/annrheumdis-2012-201531.

Pakbaz M, Pakbaz M. Cardiac involvement in eosinophilic granulomatosis with polyangiitis: a meta-analysis

of 62 case reports. J Tehran Heart Cent. 2020;15(1):18–26.

Szczeklik W, Miszalski-Jamka T, Mastalerz L, et al. Multimodality assessment of cardiac involvement

in Churg-Strauss syndrome patients in clinical remission. Circ J. 2011;75(3):649–655. doi:10.1253/circj.

cj-10-0772.

Dennert RM, van Paassen P, Schalla S, et al. Cardiac involvement in Churg-Strauss syndrome. Arthritis

Rheum. 2010;62(2):627–634. doi:10.1002/art.27263.

Vinit J, Bielefeld P, Muller G, et al. Heart involvement in Churg-Strauss syndrome: retrospective study

in French Burgundy population in past 10 years. Eur J Intern Med. 2010;21(4):341–346. doi:10.1016/j.

ejim.2010.05.004.

Neumann T, Manger B, Schmid M, et al. Cardiac involvement in Churg-Strauss syndrome: impact of

endomyocarditis. Medicine (Baltimore). 2009;88(4):236–243. doi:10.1097/MD.0b013e3181af35a5.

Zampieri M, Emmi G, Beltrami M, et al. Cardiac involvement in eosinophilic granulomatosis with polyangiitis (formerly Churg-Strauss syndrome): prospective evaluation at a tertiary referral centre. Eur J Intern

Med. 2021;85:68–79. doi:10.1016/j.ejim.2020.12.008.

Ikeda S, Usami K, Tomita M, et al. An autopsy case of eosinophilic granulomatosis with polyangiitis

with sudden cardiac death presenting cardiomyopathy and neuropathy [in Japanese]. Peripher Nerve

2014;25(1):115–120.

Sharpley FA. Missing the beat: arrhythmia as a presenting feature of eosinophilic granulomatosis with

polyangiitis. BMJ Case Rep. 2014;2014:bcr2013203413. doi:10.1136/bcr-2013-203413

Chin JY, Yi JE, Youn H. Churg-Strauss syndrome associated with rapid deterioration of left ventricular

diastolic dysfunction and conduction disturbance. J. Echocardiography. 2013;30(9):E269-E273 doi:10.1111/

echo.12314.

Budanova M, Mitrofanova L, Kozlenok A, Ryzhkova D, Maslyanskiy A, Moiseeva O. Ventricular tachycardia

as the first manifestation of Churg-Strauss syndrome. J Cardiol Cases. 2016;15(2):61–64. doi:10.1016/j.

jccase.2016.10.011.

Ozaki S. ANCA-associated vasculitis: diagnostic and therapeutic strategy. Allergol Int. 2007;56(2):87–96.

doi:10.2332/allergolint.R-07-141.

Masi AT, Hunder GG, Lie JT, et al. The American College of Rheumatology 1990 criteria for the classification of Churg-Strauss syndrome (allergic granulomatosis and angitis). Arthritis Rheum. 1990;33(8):1094–1100.

doi:10.1002/art.1780330806.

Tsurikisawa N, Oshikata C, Kinoshita A, Tsuburai T, Saito H. Longterm prognosis of 121 patients with

eosinophilic granulomatosis with polyangiitis in Japan. J Rheumatol. 2017;44(8):1206–1215. doi:10.3899/

jrheum.161436.

Jardel S, Puéchal X, Quellec AL, et al. Mortality in systemic necrotizing vasculitides: A retrospective

analysis of the French Vasculitis Study Group registry. Autoimmun Rev. 2018;17(7):653–659. doi:10.1016/j.

autrev.2018.01.022.

Morita H, Yokoyama I, Yamada N, Uno K, Nagai R. Usefulness of 18FDG13N-ammonia PET imaging for evaluation of the cardiac damage in Churg-Strauss syndrome. Eur J Nucl Med Mol Imaging.

2004;31(8):1218. doi:10.1007/s00259-004-1550-9.

Marmursztejn J, Guillevin L, Trebossen R, et al. Churg-Strauss syndrome cardiac involvement evaluated by

cardiac magnetic resonance imaging and positron-emission tomography: a prospective study on 20 patients.

Rheumatology (Oxford). 2013;52(4):642–650. doi:10.1093/rheumatology/kes155.

Horiguchi Y, Morita Y, Tsurikisawa N, Akiyama K. 123I-MIBG imaging detects cardiac involvement and

predicts cardiac events in Churg-Strauss syndrome. Eur J Nucl Med Mol Imaging. 2011;38(2):221–229.

doi:10.1007/s00259-010-1617-8.

Horiguchi Y, Tsurikisawa N, Harasawa A, et al. Detection of pulmonary involvement in eosinophilic

granulomatosis with polyangiitis (Churg-Strauss, EGPA) with 18F-fluorodeoxyglucose positron emission

Nagoya J. Med. Sci. 85. 171–178, 2023

177

doi:10.18999/nagjms.85.1.171

Yuichiro Sakurai et al

tomography. Allergol Int. 2014;63(1):121–123. doi:10.2332/allergolint.13-LE-0550.

24 Ohira H, Birnie DH, Pena E, et al. Comparison of 18F-fluorodeoxyglucose positron emission tomography

(FDG PET) and cardiac magnetic resonance (CMR) in corticosteroid-naive patients with conduction system

disease due to cardiac sarcoidosis. Eur J Nucl Med Mol Imaging. 2016;43(2):259–269. doi:10.1007/s00259015-3181-8.

25 Nordenswan HK, Lehtonen J, Ekström K, et al. Outcome of Cardiac sarcoidosis presenting with high-grade

atrioventricular block. Circ Arrhythm Electrophysiol. 2018;11(8):e006145. doi:10.1161/CIRCEP.117.006145.

26 Okada DR, Xie E, Assis F, et al. Regional abnormalities on cardiac magnetic resonance imaging and

arrhythmic events in patients with cardiac sarcoidosis. J Cardiovasc Electrophysiol. 2019;30(10):1967–1976.

doi:10.1111/jce.14082.

27 Renaldini E, Spandrio S, Cerudelli B, Affatato A, Balestrieri GP. Cardiac involvement in Churg–Strauss

syndrome: a follow-up of three cases. Eur Heart J. 1993;14(12):1712–1716. doi:10.1093/eurheartj/14.12.1712.

28 Tsurikisawa N, Taniguchi M, Saito H, et al. Treatment of Churg-Strauss syndrome with high-dose intravenous

immunoglobulin. Ann Allergy Asthma Immunol. 2004;92(1):80–87. doi:10.1016/S1081-1206(10)61714-0.

29 Tsurikisawa N, Saito H, Oshikata C, Tsuburai T, Akiyama K. High-dose intravenous immunoglobulin

treatment increases regulatory T cells in patients with eosinophilic granulomatosis with polyangiitis. J

Rheumatol. 2012;39(5):1019–1025. doi:10.3899/jrheum.110981.

30 Samson M, Puéchal X, Devilliers H, et al. Long-term outcomes 118 patients with eosinophilic granulomatosis

with polyangiitis (Churg–Strauss syndrome) enrolled in two prospective trials. J Autoimmun. 2013;43:60–69.

doi:10.1016/j.jaut.2013.03.003.

31 Hunsaker JC 3rd, O’Connor WN, Lie JT. Spontaneous coronary arterial dissection and isolated eosinophilic

coronary arteritis: sudden cardiac death in a patient with a limited variant of Churg-Strauss syndrome. Mayo

Clin Proc. 1992;67(8):761–766. doi:10.1016/s0025-6196(12)60801-5.

32 Setoguchi M, Okishige K, Sugiyama K, et al. Sudden cardiac death associated with Churg-Strauss syndrome.

Circ J. 2009;73(12):2355–2359. doi:10.1253/circj.cj-08-0926.

33 Groh M, Masciocco G, Kirchner E, et al. Heart transplantation in patients with eosinophilic granulomatosis

with polyangiitis (Churg-Strauss syndrome). J Heart Lung Transplant. 2014;33(8):842–850 doi:10.1016/j.

healun.2014.02.023.

References End

Nagoya J. Med. Sci. 85. 171–178, 2023

178

doi:10.18999/nagjms.85.1.171

...